NCT07460700

Brief Summary

Vascular bowel disease remains a socially significant and potentially fatal condition (if it develops into AMI), primarily due to delayed diagnosis. Blood biomarkers are theoretically ideal for early risk stratification (like troponins in myocardial infarction). However, the existing evidence base is characterized by low quality and high heterogeneity, which hinders their use in clinical practice. Therefore, there is an urgent and unmet clinical need for high-quality, methodologically rigorous research to validate biomarkers in MI. A current study (MESMARK) is to be undertaken to identify combinations of biomarkers that can reliably identify mesenteric ischemia (MI) and distinguish between non-transmural and transmural clinical relevant ischemia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Dec 2025Dec 2026

Study Start

First participant enrolled

December 22, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 10, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2026

Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

February 27, 2026

Last Update Submit

March 4, 2026

Conditions

Keywords

Mesenteric arteries diseaseMesenteric IschemiaBlood biomarkers

Outcome Measures

Primary Outcomes (1)

  • Increasing in the level of mesenteric ischemia (MI) markers above the reference threshold level within 1 day after enrollment in the study

    Assessment of serum markers level is intended to identify reliable serum markers or the panel of them as biomarkers for the diagnosis of MI. The endpoint is "increasing in serum marker level above the threshold reference level within 24 hours of objectively suspected MI or not". Markers with elevated above the reference threshold level will be assessed individually and in combination (as a marker panel) later to calculate their sensitivity and specificity in diagnostic of MI. These markers include intestinal fatty acid-binding protein (I-FABP), alpha-glutathione S-transferase (α-GST), ischaemia-modified albumin (IMA), D-lactate, D-dimer, adropin, hypoxia-inducible factor (HIF-1α).

    From enrollment to the 24 hours

Study Arms (1)

MA data and blood samples data

OTHER

Patients with MA lesions and suspicion of acute or chronic vascular diseases of the intestine. Patients with suspicion of AMI or CMI are to be included and blood samples are to be collected. Blood samples is the only intervention.

Diagnostic Test: Blood samples

Interventions

Blood samplesDIAGNOSTIC_TEST

Blood samples as diagnostic tests are the only intervention in the trial

MA data and blood samples data

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older, all sex
  • Initial decision, the presence of angio-visualisation of the MA and suspicion of mesenteric arteries diseases
  • Patient's consent to participate in the study
  • No pregnancy, no history of major operations on MA, the gastrointestinal tract and digestive organs (except appendectomy, endoscopic polypectomy).

You may not qualify if:

  • Consent declined by patient or relatives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Belarusian State Medical University

Minsk, Belarus

RECRUITING

MeSH Terms

Conditions

Mesenteric Ischemia

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPeritoneal DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Hleb But-Husaim, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Blood samples is to be collected from study subjects
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of the Department of Surgery and Endoscopy BSMU, MD, PhD

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 10, 2026

Study Start

December 22, 2025

Primary Completion (Estimated)

August 12, 2026

Study Completion (Estimated)

December 12, 2026

Last Updated

March 10, 2026

Record last verified: 2026-03

Locations